Free Trial
NASDAQ:RAIN

Rain Oncology Q3 2023 Earnings Report

Rain Oncology EPS Results

Actual EPS
-$0.19
Consensus EPS
-$0.27
Beat/Miss
Beat by +$0.08
One Year Ago EPS
N/A

Rain Oncology Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Rain Oncology Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
Thursday, November 9, 2023
Conference Call Time
4:00PM ET

Rain Oncology Earnings Headlines

$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.
See More Rain Oncology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rain Oncology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rain Oncology and other key companies, straight to your email.

About Rain Oncology

As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.

View Rain Oncology Profile

More Earnings Resources from MarketBeat